Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Among patients with CRC enrolled in the ColoCare Study the proportion of supplement users was found to be highest post-diagnosis (35%).36 Moreover, within an international investigation including ColoCare participants from multiple sites, Ulrich et al showed differences in plasma folate concentration between Heidelberg and the US sites, probably reflecting variation in folic acid fortification and supplement use.13 Furthermore, ColoCare has published data on RECQ helicase expression,37 NTRK3,38 RET,39 tumour-infiltrating lymphocytes and T cell receptor sequences,40 25 to 25-hydroxyvitamin D3,13 41 DNA methylation,42 to 45 miRNAs,46 47 faecal microbiota,48 to 50 metabolomics and transcriptomics,51 to 53 plasma proteins,54 gene expression,55 branched-chain amino acids,56 genetic variants,57 body composition,53 58 59 physical activity41 and dietary patterns4 in patients with CRC.

Source: Previous relevant findings from individual cohorts within the consortium. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Cohort profile: Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival: the FOCUS Consortium

Study design awaiting verification · BMJ Open · 2022

Original publication title

Cohort profile: Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival: the FOCUS Consortium

Biljana Gigic; Eline van Roekel; Andreana N Holowatyj; Stefanie Brezina; Anne J M R Geijsen; Arve Ulvik; Jennifer Ose; Janna L Koole; Victoria Damerell; Rama Kiblawi; Tanja Gumpenberger; Tengda Lin; Gry Kvalheim; Torsten Koelsch; Dieuwertje E Kok; Franzel J van Duijnhoven; Martijn J Bours; Andreas Baierl; Christopher I Li; William Grady; Kathy Vickers; Nina Habermann; Martin Schneider; Ellen Kampman; Per Magne Ueland; Alexis Ulrich; Matty Weijenberg; Andrea Gsur; Cornelia Ulrich; The FOCUS Consortium UlrichCorneliaGsurAndrea

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: What objectives does the paper state?

The overarching goal of the FOCUS (biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer (CRC) recurrence and survival) Consortium is to unravel the effect of folate and folate-mediated one-carbon metabolism (FOCM) biomarkers on CRC prognosis to provide clinically relevant advice on folate intake to cancer patients and define future tertiary prevention strategies.

Source: Purpose

Abstract: Participants

The FOCUS Consortium is an international, prospective cohort of 2401 women and men above 18 years of age who were diagnosed with a primary invasive non-metastatic (stages I: III) CRC. The consortium comprises patients from Austria, two sites from the Netherlands, Germany and two sites from the USA. Patients are recruited after CRC diagnosis and followed at 6 and 12 months after enrolment. At each time point, sociodemographic data, data on health behaviour and clinical data are collected, blood samples are drawn.

Source: Participants

Abstract: Findings to date

An increased risk of cancer recurrences was observed among patients with higher compared with lower circulating folic acid concentrations. Furthermore, specific folate species within the FOCM pathway were associated with both inflammation and angiogenesis pathways among patients with CRC. In addition, higher vitamin B6 status was associated with better quality of life at 6 months post-treatment.

Source: Findings to date

Abstract: Future plans

Better insights into the research on associations between folate and FOCM biomarkers and clinical outcomes in patients with CRC will facilitate the development of guidelines regarding folate intake in order to provide clinically relevant advice to patients with cancer, health professionals involved in patient care, and ultimately further tertiary prevention strategies in the future. The FOCUS Consortium offers an excellent infrastructure for short-term and long-term research projects and for combining additional biomarkers and data resulting from the individual cohorts within the next years, for example, microbiome data, omics and multiomics data or CT-quantified body composition data.

Source: Future plans
Authors’ abstract

Purpose

The overarching goal of the FOCUS (biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer (CRC) recurrence and survival) Consortium is to unravel the effect of folate and folate-mediated one-carbon metabolism (FOCM) biomarkers on CRC prognosis to provide clinically relevant advice on folate intake to cancer patients and define future tertiary prevention strategies.

Participants

The FOCUS Consortium is an international, prospective cohort of 2401 women and men above 18 years of age who were diagnosed with a primary invasive non-metastatic (stages I: III) CRC. The consortium comprises patients from Austria, two sites from the Netherlands, Germany and two sites from the USA. Patients are recruited after CRC diagnosis and followed at 6 and 12 months after enrolment. At each time point, sociodemographic data, data on health behaviour and clinical data are collected, blood samples are drawn.

Findings to date

An increased risk of cancer recurrences was observed among patients with higher compared with lower circulating folic acid concentrations. Furthermore, specific folate species within the FOCM pathway were associated with both inflammation and angiogenesis pathways among patients with CRC. In addition, higher vitamin B6 status was associated with better quality of life at 6 months post-treatment.

Future plans

Better insights into the research on associations between folate and FOCM biomarkers and clinical outcomes in patients with CRC will facilitate the development of guidelines regarding folate intake in order to provide clinically relevant advice to patients with cancer, health professionals involved in patient care, and ultimately further tertiary prevention strategies in the future. The FOCUS Consortium offers an excellent infrastructure for short-term and long-term research projects and for combining additional biomarkers and data resulting from the individual cohorts within the next years, for example, microbiome data, omics and multiomics data or CT-quantified body composition data.

Publication and source details

Original title: Cohort profile: Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival: the FOCUS Consortium

Biljana Gigic; Eline van Roekel; Andreana N Holowatyj; Stefanie Brezina; Anne J M R Geijsen; Arve Ulvik; Jennifer Ose; Janna L Koole; Victoria Damerell; Rama Kiblawi; Tanja Gumpenberger; Tengda Lin; Gry Kvalheim; Torsten Koelsch; Dieuwertje E Kok; Franzel J van Duijnhoven; Martijn J Bours; Andreas Baierl; Christopher I Li; William Grady; Kathy Vickers; Nina Habermann; Martin Schneider; Ellen Kampman; Per Magne Ueland; Alexis Ulrich; Matty Weijenberg; Andrea Gsur; Cornelia Ulrich; The FOCUS Consortium UlrichCorneliaGsurAndrea

BMJ Open · 2022

Correspondence to Professor Cornelia Ulrich; neli.ulrich@hci.utah.edu; Professor Andrea Gsur; andrea.gsur@meduniwien.ac.at

EK, PMU, AU, MW, AG and CU are joint senior authors.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.2022https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. Rodger C. Haggitt Endowed Chair n.a. http://dx.doi.org/10.13039/100013743World Cancer Research Fund International 2016/1620UM 2012-5653UW 2013-5927UW 2015-7946 http://dx.doi.org/10.13039/501100004622KWF Kankerbestrijding UM-2010-4867UM-2012-5653UW2013-6397UW2014-6877 FWF Austrian Science Fund API02104FW Matthias-Lackas Foundation n.a. National Institutes of Health/National Cancer Institute P01 CA077852P30 CA042014P30 CA15704R01 CA194663R01 CA220004R01CA189184T32 HG008962U01 CA152756U01 CA206110 http://dx.doi.org/10.13039/501100013514Wereld Kanker Onderzoek Fonds 2014/1179 R.A.C.E. Charities n.a. Cottrell Family Fund, Listwin Family Foundation n.a. The Netherlands Organisation for Scientific Research 016.Veni.188.082 Research Council Norway/Norwegian Cancer Society (RNC) n.a. ERA-NET on Translational Cancer Research (TRANSCAN) FOCUS I2104-B26MetaboCCC I 1578: B19 Stiftung LebensBlicke n.a. http://dx.doi.org/10.13039/100005895Fred Hutchinson Cancer Research Center n.a. The Netherlands Organization for Health Research and Development n.a. Seattle Translational Tumor Research program n.a. German Ministry of Education and Research 01KD2101D01KT150301KT1512 http://dx.doi.org/10.13039/100016244Health Foundation Limburg 00005739

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T21:23:16.424666+00:00

DOI: 10.1136/bmjopen-2022-062930 · PMC9772678